These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 20876984)
21. Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection. Singh D; Goel D; Bhatnagar R Vaccine; 2015 Jun; 33(24):2786-92. PubMed ID: 25930114 [TBL] [Abstract][Full Text] [Related]
22. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Oliveira SC; Splitter GA Vaccine; 1996 Jul; 14(10):959-62. PubMed ID: 8873388 [TBL] [Abstract][Full Text] [Related]
23. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection. Tabynov K; Kydyrbayev Z; Ryskeldinova S; Yespembetov B; Zinina N; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Gotskina T; Sansyzbay A Vaccine; 2014 Apr; 32(18):2034-41. PubMed ID: 24598723 [TBL] [Abstract][Full Text] [Related]
24. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella. Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411 [TBL] [Abstract][Full Text] [Related]
25. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of Th1/Th2-Related Immune Response against Recombinant Proteins of Brucella abortus Infection in Mice. Im YB; Park WB; Jung M; Kim S; Yoo HS J Microbiol Biotechnol; 2016 Jun; 26(6):1132-9. PubMed ID: 27012238 [TBL] [Abstract][Full Text] [Related]
27. Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Oliveira SC; Splitter GA Infect Immun; 1994 Nov; 62(11):5201-4. PubMed ID: 7927808 [TBL] [Abstract][Full Text] [Related]
28. Expression of human serum albumin--L7/L12 (Brucella abortus ribosomal protein) fusion protein in Saccharomyces cerevisiae. Pakzad I; Rezaee A; Emaneini M; Hosseini AZ; Tabbaraee B; Taherikalani M Pol J Microbiol; 2009; 58(2):99-104. PubMed ID: 19824392 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity Analysis of a Novel Subunit Vaccine Candidate Molecule-Recombinant L7/L12 Ribosomal Protein of Brucella suis. Du ZQ; Li X; Wang JY Appl Biochem Biotechnol; 2016 Aug; 179(8):1445-55. PubMed ID: 27075455 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB/c mice. Golshani M; Amani M; Siadat SD; Nejati-Moheimani M; Arsang A; Bouzari S Mol Immunol; 2018 Nov; 103():306-311. PubMed ID: 30343119 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Immune Effects Between Zhu L; Wang Q; Wang Y; Xu Y; Peng D; Huang H; Hu L; Wei K; Zhu R Front Vet Sci; 2020; 7():576. PubMed ID: 33195494 [No Abstract] [Full Text] [Related]
32. Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. Rafiei A; Ardestani SK; Kariminia A; Keyhani A; Mohraz M; Amirkhani A J Infect; 2006 Nov; 53(5):315-24. PubMed ID: 16488475 [TBL] [Abstract][Full Text] [Related]
33. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277 [TBL] [Abstract][Full Text] [Related]
34. Determination of intracellular cytokines produced by Th1 and Th2 cells using flow cytometry in patients with brucellosis. Akbulut HH; Kilic SS; Bulut V; Ozden M FEMS Immunol Med Microbiol; 2005 Aug; 45(2):253-8. PubMed ID: 15949930 [TBL] [Abstract][Full Text] [Related]
35. Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation. Rosinha GMS; Myioshi A; Azevedo V; Splitter GA; Oliveira SC J Med Microbiol; 2002 Aug; 51(8):661-671. PubMed ID: 12171297 [TBL] [Abstract][Full Text] [Related]
36. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544. Goel D; Bhatnagar R Mol Immunol; 2012 Jun; 51(2):159-68. PubMed ID: 22464098 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous Immunization with Omp25 and L7/L12 Provides Protection against Brucellosis in Mice. Gupta S; Mohan S; Somani VK; Aggarwal S; Bhatnagar R Pathogens; 2020 Feb; 9(2):. PubMed ID: 32102449 [TBL] [Abstract][Full Text] [Related]
38. Th2-related immune responses by the Brucella abortus cellular antigens, malate dehydrogenase, elongation factor, and arginase. Im YB; Shim S; Park WB; Kim S; Yoo HS Microb Pathog; 2017 Sep; 110():7-13. PubMed ID: 28629726 [TBL] [Abstract][Full Text] [Related]
39. Brucella abortus phosphoglyceromutase and dihydrodipicolinate reductase induce Th1 and Th2-related immune responses. Li Z; Zhang H; Zhang J; Xi L; Yang G; Wang S; Zhou Q; Zhang X; Zhang J World J Microbiol Biotechnol; 2018 Jan; 34(2):22. PubMed ID: 29302824 [TBL] [Abstract][Full Text] [Related]
40. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches. Saadi M; Karkhah A; Nouri HR Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]